mhurhangee/patent-ind-claim-en huggingface dataset:
An implantable a prosthetic aortic valve comprising: a radially collapsible and expandable annular frame the frame having three angularly spaced commissure attachment posts and a plurality of angularly spaced, axial struts that are interconnected by at least three rows of circumferential struts including an inflow row of circumferential struts adjacent the inflow end of the frame , an outflow row of circumferential struts adjacent the outflow end of the frame , and an intermediate row of circumferential struts positioned axially between the inflow and outflow rows of angled struts along the length of the frame , each row of circumferential struts including struts arranged in a zig-zag pattern extending around the circumference of the frame , wherein pairs of adjacent struts of the intermediate row of circumferential struts and pairs of adjacent struts of the outflow rows of circumferential struts form cells; an annular skirt member positioned inside of and secured to the frame ; a leaflet structure comprising three leaflets, the leaflet structure having a scalloped lower edge portion secured to an inner surface of the skirt member and three commissures formed at adjacent sides of the leaflets, each commissure being attached to one of the commissure attachment posts, the skirt member disposed between the frame and the leaflet structure ; characterised in that the frame is made of a nickel-cobalt-chromium alloy and that the valve has a reinforcing strip , separate from the skirt member , sutured to an inner surface of the scalloped lower edge portion of the leaflet structure . a radially collapsible and expandable annular frame the frame having three angularly spaced commissure attachment posts and a plurality of angularly spaced, axial struts that are interconnected by at least three rows of circumferential struts including an inflow row of circumferential struts adjacent the inflow end of the frame , an outflow row of circumferential struts adjacent the outflow end of the frame , and an intermediate row of circumferential struts positioned axially between the inflow and outflow rows of angled struts along the length of the frame , each row of circumferential struts including struts arranged in a zig-zag pattern extending around the circumference of the frame , wherein pairs of adjacent struts of the intermediate row of circumferential struts and pairs of adjacent struts of the outflow rows of circumferential struts form cells; an annular skirt member positioned inside of and secured to the frame ; a leaflet structure comprising three leaflets, the leaflet structure having a scalloped lower edge portion secured to an inner surface of the skirt member and three commissures formed at adjacent sides of the leaflets, each commissure being attached to one of the commissure attachment posts, the skirt member disposed between the frame and the leaflet structure ; characterised in that the frame is made of a nickel-cobalt-chromium alloy and that the valve has a reinforcing strip , separate from the skirt member , sutured to an inner surface of the scalloped lower edge portion of the leaflet structure .
A nucleic acid comprising a polynucleotide having a nucleotide sequence selected from the group consisting of: (a) a nucleotide sequence selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:8; (b) a nucleotide sequence being at least 95 %, at least 97 %, at least 98 %, at least 99 % identical to SEQ ID NO:1 over the overall length of SEQ ID NO:1 or to SEQ ID NO:8 over the overall length of SEQ ID NO:8; (c) a nucleotide sequence encoding a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13 and SEQ ID NO:14; (d) a nucleotide sequence encoding a polypeptide having an amino acid sequence which is at least 95 % identical to SEQ ID NO:2 over the overall length of SEQ ID NO:2, at least 95 % identical to SEQ ID NO:3 over the overall length of SEQ ID NO:3, at least 95 % identical to SEQ ID NO:4 over the overall length of SEQ ID NO:4, at least 95 % identical to SEQ ID NO:5 over the overall length of SEQ ID NO:5, at least 95 % identical to SEQ ID NO:6 over the overall length of SEQ ID NO:6 or at least 95 % identical to SEQ ID NO:7 over the overall length of SEQ ID NO:7; and (e) the complementary strand of any of the nucleotide sequences of (a) to (d), wherein the nucleic acid encodes a paramyxovirus. (a) a nucleotide sequence selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:8; (b) a nucleotide sequence being at least 95 %, at least 97 %, at least 98 %, at least 99 % identical to SEQ ID NO:1 over the overall length of SEQ ID NO:1 or to SEQ ID NO:8 over the overall length of SEQ ID NO:8; (c) a nucleotide sequence encoding a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13 and SEQ ID NO:14; (d) a nucleotide sequence encoding a polypeptide having an amino acid sequence which is at least 95 % identical to SEQ ID NO:2 over the overall length of SEQ ID NO:2, at least 95 % identical to SEQ ID NO:3 over the overall length of SEQ ID NO:3, at least 95 % identical to SEQ ID NO:4 over the overall length of SEQ ID NO:4, at least 95 % identical to SEQ ID NO:5 over the overall length of SEQ ID NO:5, at least 95 % identical to SEQ ID NO:6 over the overall length of SEQ ID NO:6 or at least 95 % identical to SEQ ID NO:7 over the overall length of SEQ ID NO:7; and (e) the complementary strand of any of the nucleotide sequences of (a) to (d),
Three-dimensional printing installation of a medical device directly at a location where the medical device is to be used, comprising a container comprising inside it: - a production module comprising a 3D printer ; the installation being characterised in that the container also comprises: - a clean room , separate from the production module , comprising means for washing and disinfecting the printed medical device, and a machine for packaging the washed and disinfected medical device. - a production module comprising a 3D printer ; - a clean room , separate from the production module , comprising means for washing and disinfecting the printed medical device, and a machine for packaging the washed and disinfected medical device.
Design method of an intraoral device , splint type, through the use of CAD software, where a file based on the intraoral scan or scan of the previous models of a patient is opened and the data of at least one arch of the patient in the form of a mesh or piece, where the design method is characterized by comprising the steps of: - segmenting the arch mesh into the different dental pieces by means of a thermal simulation by assigning heat points of a temperature (A) to dental pieces and points of heat of another temperature (B) to the dental pieces adjacent to those that comprise heat points of temperature (A), so that the adjacent dental pieces have different heat points (A, B), - defining at least some local vectors and centroids to each dental piece , which will define the directions of a support curve of a final contour of the intraoral device , - segmenting the arch mesh into the different dental pieces by means of a thermal simulation by assigning heat points of a temperature (A) to dental pieces and points of heat of another temperature (B) to the dental pieces adjacent to those that comprise heat points of temperature (A), so that the adjacent dental pieces have different heat points (A, B), - defining at least some local vectors and centroids to each dental piece , which will define the directions of a support curve of a final contour of the intraoral device ,
Pencil provided with an end piece for a capacitive screen, the pencil comprising an insulating body and a conductive longitudinal internal core extending in an axial direction (X) of said pencil, said end piece comprising a base on which is mounted a contact pad for a capacitive screen, and a contactor which provides an electrical connection between the pad and the conductive longitudinal internal core of the pencil, said contactor comprising a conductive projection (16, 18; 18'), the contactor comprising a spring working in compression.
A prosthetic foot comprising: a plate-like foot member having a proximal portion and a distal portion , wherein the distal portion is generally horizontal, the foot member having a curved portion between the proximal portion and the distal portion; an adapter coupled to the proximal portion of the foot member, wherein the adapter is generally vertical and configured to couple the proximal portion of the foot member to a prosthetic pylon or socket; and a resilient heel member disposed below the foot member, wherein the heel member has a concave front surface coupled to the curved portion of the foot member and a rear surface facing generally away from the foot member, the rear surface having a convex curvature, wherein the rear surface comprises a lip that protrudes from the rear surface, the lip configured to engage a corresponding structure inside a foot cover to removably secure the foot cover to the foot member and the heel member. a plate-like foot member having a proximal portion and a distal portion , wherein the distal portion is generally horizontal, the foot member having a curved portion between the proximal portion and the distal portion; an adapter coupled to the proximal portion of the foot member, wherein the adapter is generally vertical and configured to couple the proximal portion of the foot member to a prosthetic pylon or socket; and a resilient heel member disposed below the foot member, wherein the heel member has a concave front surface coupled to the curved portion of the foot member and a rear surface facing generally away from the foot member, the rear surface having a convex curvature, wherein the rear surface comprises a lip that protrudes from the rear surface, the lip configured to engage a corresponding structure inside a foot cover to removably secure the foot cover to the foot member and the heel member.
A drying apparatus comprising: a main body having an entrance hole through which air is introduced thereinto and having outlets through which the air is discharged toward a front of the main body ; a fan assembly disposed inside the entrance hole of the main body to generate a flow of the air; a filter assembly installable at the entrance hole of the main body and having filters (184; 186; 188) to purify the air introduced into the main body , a duct communicating with the fan assembly to allow the flow of the air to be delivered to the outlets ; a moving bar movably mounted to the main body to discharge air introduced from an outside of the moving bar while moving up and down along the main body ; and a drive assembly disposed at the main body to supply a driving force to move the moving bar up and down. a main body having an entrance hole through which air is introduced thereinto and having outlets through which the air is discharged toward a front of the main body ; a fan assembly disposed inside the entrance hole of the main body to generate a flow of the air; a filter assembly installable at the entrance hole of the main body and having filters (184; 186; 188) to purify the air introduced into the main body , a duct communicating with the fan assembly to allow the flow of the air to be delivered to the outlets ; a moving bar movably mounted to the main body to discharge air introduced from an outside of the moving bar while moving up and down along the main body ; and a drive assembly disposed at the main body to supply a driving force to move the moving bar up and down.
A process for the continuous production of an optically active carbonyl compound by asymmetric hydrogenation of a prochiral α,β-unsaturated carbonyl compound with hydrogen in the presence of a homogeneous rhodium catalyst that has at least one chiral ligand, wherein a liquid reaction mixture comprising the prochiral α,β-unsaturated carbonyl compound is subjected in a first, backmixed reactor to a gas/liquid two-phase hydrogenation, and the liquid reaction mixture is then further hydrogenated in a second reactor, wherein the prochiral α,β-unsaturated carbonyl compound is employed in the first reactor in a concentration from 3% to 20% by weight. a liquid reaction mixture comprising the prochiral α,β-unsaturated carbonyl compound is subjected in a first, backmixed reactor to a gas/liquid two-phase hydrogenation, and the liquid reaction mixture is then further hydrogenated in a second reactor, wherein the prochiral α,β-unsaturated carbonyl compound is employed in the first reactor in a concentration from 3% to 20% by weight.
A method of processing a transaction based on a blockchain integrated station, wherein the blockchain integrated station comprises a Central Processing Unit, CPU, and a smart network card and is any node of a blockchain network, and the method comprises: when the blockchain integrated station receives a transaction through the smart network card, writing (S300), by the smart network card, the received transaction into a network card cache, sending, by the smart network card, the received transaction to the CPU and writing, by the CPU, the received transaction into a CPU cache; performing (S302), by the smart network card, a consensus interaction with other nodes of the blockchain network based on the transaction in the network card cache in a process that the blockchain integrated station participates in a blockchain consensus; determining and sending (S304), by the smart network card, a to-be-executed transaction list to the CPU based on a result of the blockchain consensus, wherein the to-be-executed transaction list comprises a transaction identifier of each to-be-executed transaction determined based on the present blockchain consensus; and executing (S306), by the CPU, transaction based on the to-be-executed transaction list and completing transaction chaining. when the blockchain integrated station receives a transaction through the smart network card, writing (S300), by the smart network card, the received transaction into a network card cache, sending, by the smart network card, the received transaction to the CPU and writing, by the CPU, the received transaction into a CPU cache; performing (S302), by the smart network card, a consensus interaction with other nodes of the blockchain network based on the transaction in the network card cache in a process that the blockchain integrated station participates in a blockchain consensus; determining and sending (S304), by the smart network card, a to-be-executed transaction list to the CPU based on a result of the blockchain consensus, wherein the to-be-executed transaction list comprises a transaction identifier of each to-be-executed transaction determined based on the present blockchain consensus; and executing (S306), by the CPU, transaction based on the to-be-executed transaction list and completing transaction chaining.
A method for displaying a widget on an electronic device that supports at least one low power display mode, the method comprising: identifying characteristics of a first widget to be displayed on a low power display, LPD, of the electronic device, wherein the characteristics of the first widget include at least one of histogram information, color depth, luminance, or pixel power of the widget; determining compatibility of the first widget with the LPD based on the characteristics of the first widget and constraints associated with the LPD; in response to determining that the first widget is compatible with the LPD, transforming the first widget based on the characteristics of the first widget and the constraints associated with the LPD, and displaying the transformed first widget on the LPD; and in response to determining that the first widget is not compatible with the LPD, recommending a second widget that is compatible with the LPD based on characteristics of the second widget and the constraints associated with the LPD, wherein the characteristics of the second widget include at least one of histogram information, color depth, luminance, or pixel power of the widget; transforming the second widget based on the characteristics of the second widget and the constraints associated with the LPD; and displaying the second widget on the LPD, wherein the first widget and the second widget are different widgets that provide same type of information; wherein the transforming of the first widget or the second widget comprises at least one of applying frame rate restriction or applying minimal color filter. identifying characteristics of a first widget to be displayed on a low power display, LPD, of the electronic device, wherein the characteristics of the first widget include at least one of histogram information, color depth, luminance, or pixel power of the widget; determining compatibility of the first widget with the LPD based on the characteristics of the first widget and constraints associated with the LPD; in response to determining that the first widget is compatible with the LPD, transforming the first widget based on the characteristics of the first widget and the constraints associated with the LPD, and displaying the transformed first widget on the LPD; and in response to determining that the first widget is not compatible with the LPD, recommending a second widget that is compatible with the LPD based on characteristics of the second widget and the constraints associated with the LPD, wherein the characteristics of the second widget include at least one of histogram information, color depth, luminance, or pixel power of the widget; transforming the second widget based on the characteristics of the second widget and the constraints associated with the LPD; and displaying the second widget on the LPD, wherein the first widget and the second widget are different widgets that provide same type of information; wherein the transforming of the first widget or the second widget comprises at least one of applying frame rate restriction or applying minimal color filter.
A method comprising: receiving, by a first base station from a second base station, a request for a context of a wireless device , wherein the request comprises assistance information for a small data transmission, SDT, procedure of the wireless device in a radio resource control, RRC, inactive state, the assistance information indicating whether: no further data associated with the SDT procedure is expected; or further data associated with the SDT procedure is expected; and sending, by the first base station to the wireless device in the RRC inactive state via the second base station, downlink data associated with the SDT procedure. receiving, by a first base station from a second base station, a request for a context of a wireless device , wherein the request comprises assistance information for a small data transmission, SDT, procedure of the wireless device in a radio resource control, RRC, inactive state, the assistance information indicating whether: no further data associated with the SDT procedure is expected; or further data associated with the SDT procedure is expected; and no further data associated with the SDT procedure is expected; or further data associated with the SDT procedure is expected; and sending, by the first base station to the wireless device in the RRC inactive state via the second base station, downlink data associated with the SDT procedure.
A sealing foil for closing a packaging container comprising: a pre-cut first layer ; a second layer , connected to the first layer and coextensive therewith over the full extent of the second layer; wherein the first layer is pre-cut with a plurality of tear lines defining a tearing path leading from a pull tab to a tear end such that a central portion of the sealing foil can be removed to provide an access opening to the container, characterized in that the second layer is a hermetic layer, and in that a lead-in tear line is contiguous with a circumferential tear line and curves tangentially to but does not cross, the circumferential tear line such that uncontrolled ripping of the sealing foil is prevented. a pre-cut first layer ; a second layer , connected to the first layer and coextensive therewith over the full extent of the second layer; wherein the first layer is pre-cut with a plurality of tear lines defining a tearing path leading from a pull tab to a tear end such that a central portion of the sealing foil can be removed to provide an access opening to the container, characterized in that the second layer is a hermetic layer, and in that a lead-in tear line is contiguous with a circumferential tear line and curves tangentially to but does not cross, the circumferential tear line such that uncontrolled ripping of the sealing foil is prevented.
A polymeric composition comprising: a silane functionalized polyolefin; a brominated flame retardant having a Temperature of 5% Mass Loss from 350°C to 500°C and from 2 wt% to 50 wt% Retained Mass at 650°C, wherein the 5% Mass Loss and Retained Mass at 650°C are measured according to Thermogravimetric Analysis; and a zinc (Zn) flame retardant synergist, wherein the polymeric composition is free of antimony trioxide and has a zinc to bromine (Br) molar ratio (Zn:Br molar ratio) of greater than 0.0 to 0.160. a silane functionalized polyolefin; a brominated flame retardant having a Temperature of 5% Mass Loss from 350°C to 500°C and from 2 wt% to 50 wt% Retained Mass at 650°C, wherein the 5% Mass Loss and Retained Mass at 650°C are measured according to Thermogravimetric Analysis; and a zinc (Zn) flame retardant synergist, wherein the polymeric composition is free of antimony trioxide and has a zinc to bromine (Br) molar ratio (Zn:Br molar ratio) of greater than 0.0 to 0.160.
A sustained-release oral dosage form comprising at least one active ingredient which is ruxolitinib, or a pharmaceutically acceptable salt thereof, and at least one sustained-release matrix former which is hydroxypropyl methylcellulose, wherein said ruxolitinib, or pharmaceutically acceptable salt thereof, is present in said dosage form in an amount of about 10 to about 60 mg on a free base basis, and wherein said hydroxypropyl methylcellulose is present in said dosage form in an amount up to 30% by weight; wherein administration of said dosage form to a human results in a ratio of mean peak plasma concentration (C max ) to mean 12-hour plasma concentration (C 12h ) of ruxolitinib of 2 to 7, and a mean half-life (t 1/2 ) of from about 3.5 hours to about 11 hours.